Conversations in Health Literacy Using AI Technology for Osteoarthritis Patients (CHAT-OA)

April 10, 2026 updated by: University of California, Davis

CHAT-OA: Conversations in Health Literacy Using AI Technology for Osteoarthritis Patients

The goal of this clinical trial is to assess the use of a generative artificial intelligence large language model chatbot in improving decision making factors in patients with hip and knee osteoarthritis. The main questions it aims to answer are:

Does the use of an artificial intelligence chatbot have an effect on decisional conflict and anxiety related to decision making? Are changes in decisional conflict correlated with changes in patient reported outcomes? Are changes in decisional conflict correlated with health literacy? Participants will interact with an artificial intelligence chatbot prior to their clinic visit with an orthopaedic surgeon, using a structured prompt.

Study Overview

Status

Active, not recruiting

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Sacramento, California, United States, 95817
        • University of California Davis Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult
  • Ability to read and write in English
  • All races and ethnicities
  • Clinical symptoms of hip and/or knee osteoarthritis

Exclusion Criteria:

  • Inability to read and write in English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard of care
This arm will undergo standard clinical care without the intervention.
Experimental: Artificial Intelligence Chatbot
This arm will interact with an artificial intelligence chatbot prior to their clinic visit.
The intervention is a generative artificial intelligence large language model chatbot that has a structured prompt with fill-in-the-blank style questions that the participant will complete.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Decisional Conflict Scale
Time Frame: At three time points: Within one week after the clinic visit, 1 month after the clinic visit, 6 months after the clinic visit.
16 questions with Likert scale style answers ranging from 0 to 4. The raw score is converted to a score out of 100. The score ranges from 0 (no decisional conflict) to 100 (extremely high decisional conflict).
At three time points: Within one week after the clinic visit, 1 month after the clinic visit, 6 months after the clinic visit.
Beck Anxiety Inventory
Time Frame: At three time points: Within one week after the clinic visit, 1 month after the clinic visit, 6 months after the clinic visit.
21 questions with Likert scale style answers ranging from 0 to 4. The raw score is the sum of the answers, which is converted to a score out of 100. The score ranges from 0 (low anxiety) to 63 (high anxiety).
At three time points: Within one week after the clinic visit, 1 month after the clinic visit, 6 months after the clinic visit.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee injury and Osteoarthritis Outcome Score for Joint Replacement
Time Frame: At enrollment
7 questions with Likert scale style answers ranging from 0 to 4. The raw score is the sum of the answers, which is converted to a score out of 100. The score ranges from 0 (total knee disability) to 100 (perfect knee health).
At enrollment
Hip dysfunction and Osteoarthritis Outcome Score for Joint Replacement
Time Frame: At enrollment
6 questions with Likert scale style answers ranging from 0 to 4. The raw score is the sum of the answers, which is converted to a score out of 100. The score ranges from 0 (total hip disability) to 100 (perfect hip health).
At enrollment
Patient-Reported Outcomes Measurement Information System Global Health Version 1.2
Time Frame: At enrollment
10 questions with Likert scale style answers ranging from 1 to 5 and 1 question about pain with answers from 0 to 10. The questions are grouped into 4 sub-groups corresponding to physical and mental health main groups, in addition to the pain score. The raw scores are a sum of the answers for both physical and mental health range from 4 (poor physical or mental health) to 20 (best possible physical or mental health). The raw score is then converted to a t-score using the associated tables with the range 16.2 (worst possible physical or mental health) to 67.7 (best possible physical or mental health). The t-score is interpreted in comparison to the general population that has a mean of 50 and standard deviation of 10.
At enrollment

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale Pain Score
Time Frame: At enrollment
3 questions evaluating pain and different time points, each with answers ranging from 0 (no pain) to 100 (worst pain imaginable).
At enrollment
Health Literacy Single Item Screener
Time Frame: At enrollment
Both questions 1 and 2 have Likert scale style answers from 1 (limited ability to navigate healthcare scenarios independently) to 5 (adequate ability to navigate healthcare scenarios independently).
At enrollment
Literacy in Musculoskeletal Problems
Time Frame: At enrollment
9 questions each with 4 answers, in addition to an "I don't know" selection. The total score is the sum of the correct answers ranging from 0 (poor musculoskeletal health literacy) to 9 (excellent musculoskeletal health literacy).
At enrollment
Rapid Estimate of Adult Literacy in Medicine - Short Form
Time Frame: At the first clinic visit after enrollment
7-item word recognition test to provide clinicians with a valid quick assessment of patient health literacy. The test is administered in-person by a clinician. The participant is given a list of words by a clinician and asked to pronounce the words. The clinician listens and evaluates the number of words the participant pronounces correctly and the total score is based on the number of words that are correctly pronounced. A higher score is indicative of higher health literacy. The maximum score of 7 is correlated with high health literacy equivalent to high school education or greater, and a participants ability to read most patient education materials. The minimum score of 0 is associated with low health literacy equivalent to third grade education or below, and a participants inability to read most low-literacy patient education materials.
At the first clinic visit after enrollment
Flesch-Kincaid Readability Test
Time Frame: Within 1 month of AI chatbot use
This test will be used to evaluate the readability of the chatbot outputs that are presented to the participants, and will be conducted by an investigator. This test analyzes free text and determines a readability score ranging from 0 (very difficult to read) to 100 (very easy to read), and corresponds to the education level required to read the text.
Within 1 month of AI chatbot use
Simple Measure of Gobbleygook
Time Frame: Within 1 month of AI chatbot use
This test will be used to evaluate the readability of the chatbot outputs that are presented to the participants and it will be conducted by an investigator. This test analyzes free text and determines a readability score with a minimum of 4.1721 and a maximum that is theoretically infinite. The number of the score is equivalent to the approximate school grade level required to read the text.
Within 1 month of AI chatbot use
5-point Likert Safety-Harm Scale
Time Frame: Within 1 week of AI chatbot use
This safety evaluation tool will be used by a physician to assess chatbot outputs that are presented to the participant with a Likert scale ranging from 0 (no likelihood of harm) to 5 (high likelihood of harm).
Within 1 week of AI chatbot use
Newest Vital Sign
Time Frame: At enrollment
This measure involves participants answering a series of questions based on their interpretation of a nutrition label. It includes 5 primary questions with an additional conditional question, making up to 6 questions in total, depending on the participant's responses. This assessment is designed to evaluate health literacy, specifically the ability to understand and apply nutritional information. The score is the sum of the correct answers, ranging from 0 (indicating limited health literacy) to 6 (indicating adequate health literacy).
At enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Zachary C Lum, DO, University of California, Davis

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 6, 2025

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2026

Study Registration Dates

First Submitted

November 22, 2024

First Submitted That Met QC Criteria

January 10, 2025

First Posted (Actual)

January 16, 2025

Study Record Updates

Last Update Posted (Actual)

April 14, 2026

Last Update Submitted That Met QC Criteria

April 10, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis

Clinical Trials on Artificial Intelligence Chatbot

Subscribe